XML 26 R19.htm IDEA: XBRL DOCUMENT v3.24.1.u1

ACCRUED LIABILITIES (Tables)

3 Months Ended

Mar. 31, 2024

Payables and Accruals [Abstract]

Schedule of accrued liabilities

Accrued liabilities consisted of the following as of March 31, 2024 and December 31, 2023:

		MARCH 31,				DECEMBER 31,
(In thousands)		2024				2023
CRO and clinical trial costs		$	19,695			$	23,541
Manufacturing activities			10,593				14,629
Professional legal and accounting fees			1,061				556
Interest payable			896				768
Other			1,646				814
		$	33,891			$	40,308

X

- References

No definition available.

+ Details

Name:	us-gaap_PayablesAndAccrualsAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the components of accrued liabilities.

+ References

No definition available.

+ Details

Name:	us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration